# "Effects of the Vaccin Against COVID 19 in a Cohort of Dialysis Patients: Adverse Events and Immunological Response"

> **NCT05055531** · — · UNKNOWN · sponsor: **Raincy Montfermeil Hospital Group** · enrollment: 60 (estimated)

## Conditions studied

- COVID Epidemic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05055531
- **Lead sponsor:** Raincy Montfermeil Hospital Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-08
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05055531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05055531, ""Effects of the Vaccin Against COVID 19 in a Cohort of Dialysis Patients: Adverse Events and Immunological Response"". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05055531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*